Association of CD57+Natural Killer Cells with Better Overall Survival in DLBCL Patients
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Jeong Hyeon | - |
dc.contributor.author | Kwak, Yoon Jin | - |
dc.contributor.author | Kim, Chul Hwan | - |
dc.contributor.author | Kim, Insun | - |
dc.date.accessioned | 2021-09-07T09:53:40Z | - |
dc.date.available | 2021-09-07T09:53:40Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2011-08 | - |
dc.identifier.issn | 1738-1843 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/111887 | - |
dc.description.abstract | Background: Malignant tumor cells may evoke the innate and adaptive immune systems. Various immune cells are involved in this immune reaction, and tumor infiltrating lymphocytes, macrophages, natural killer (NK) cells are associated with patient prognosis for solid tumors. Methods: Seventy-eight patients who were diagnosed with diffuse large B cell lymphoma (DLBCL) between 2001 and 2009 were selected. CD57+ NK cells, CD68+ tumor associated macrophages (TAMs), and CD4+ and CD8+ T cells were evaluated in tissue sections using immunohistochemical staining and compared with clinical parameters including age, gender, performance status, clinical stage, serum lactic dehydrogenase level, number of extranodal sites, international prognostic index score, chemotherapy response, and survival. Results: Patients with high numbers of CD57+ NK cells had a significantly higher overall survival rate than patients with low numbers of CD57+ NK cells. However, no significant difference was observed between the number of CD57+ NK cells and other prognostic parameters. The number of CD68+ TAMs and CD4+ or CD8+ T cells was not significantly correlated with prognostic factors in patients with DLBCL. Conclusions: An evaluation of tumor infiltrating CD57+ NK cells is recommended as a prognostic indicator in patients with DLBCL. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN SOCIETY PATHOLOGISTS | - |
dc.subject | TUMOR-ASSOCIATED MACROPHAGES | - |
dc.subject | HODGKINS-LYMPHOMA | - |
dc.subject | INFILTRATING LYMPHOCYTES | - |
dc.subject | PROGNOSTIC-SIGNIFICANCE | - |
dc.subject | TISSUE MICROARRAY | - |
dc.subject | IMMUNE-RESPONSE | - |
dc.subject | POTENTIAL ROLE | - |
dc.subject | T-CELLS | - |
dc.subject | EXPRESSION | - |
dc.subject | CANCER | - |
dc.title | Association of CD57+Natural Killer Cells with Better Overall Survival in DLBCL Patients | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Chul Hwan | - |
dc.contributor.affiliatedAuthor | Kim, Insun | - |
dc.identifier.doi | 10.4132/KoreanJPathol.2011.45.4.361 | - |
dc.identifier.scopusid | 2-s2.0-80052998705 | - |
dc.identifier.wosid | 000294942100005 | - |
dc.identifier.bibliographicCitation | KOREAN JOURNAL OF PATHOLOGY, v.45, no.4, pp.361 - 370 | - |
dc.relation.isPartOf | KOREAN JOURNAL OF PATHOLOGY | - |
dc.citation.title | KOREAN JOURNAL OF PATHOLOGY | - |
dc.citation.volume | 45 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 361 | - |
dc.citation.endPage | 370 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001580032 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Pathology | - |
dc.relation.journalWebOfScienceCategory | Pathology | - |
dc.subject.keywordPlus | TUMOR-ASSOCIATED MACROPHAGES | - |
dc.subject.keywordPlus | HODGKINS-LYMPHOMA | - |
dc.subject.keywordPlus | INFILTRATING LYMPHOCYTES | - |
dc.subject.keywordPlus | PROGNOSTIC-SIGNIFICANCE | - |
dc.subject.keywordPlus | TISSUE MICROARRAY | - |
dc.subject.keywordPlus | IMMUNE-RESPONSE | - |
dc.subject.keywordPlus | POTENTIAL ROLE | - |
dc.subject.keywordPlus | T-CELLS | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | CANCER | - |
dc.subject.keywordAuthor | Lymphoma, large B-cell, diffuse | - |
dc.subject.keywordAuthor | Killer cells, natural | - |
dc.subject.keywordAuthor | CD57 | - |
dc.subject.keywordAuthor | Prognosis | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.